Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Synthetic Biologics Inc.
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentDiscovery
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat & prevent irritable bowel syndrome (IBS)
Regulatory Designation
PartnerIntrexon Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today